NXT Nutritionals to host ‘Spring for a Cure’ for Type 1 diabetes
HOLYOKE, Mass. NXT Nutritionals Holdings, a developer and marketer of natural sweeteners, food and beverage products, on Thursday announced that former NBA Rookie of the Year, Ralph Lee Sampson, Jr., will be making a personal appearance on behalf of NXT at the Juvenile Diabetes Research Foundation International’s “Spring for a Cure” event April 30.
“We are excited to have [Sampson] join us at the Spring for a Cure event next week,” stated Mike McCarthy, president and CEO of NXT Nutritionals. “He has been actively supporting the research and the fight for a cure for diabetes, especially since hitting close to home with one of his daughters having the disease. We want to thank him for taking this opportunity to help us educate those attending the event about our Susta Natural Sweetener.”
The “Spring for a Cure” event, of which NXT is a sponsor, is a culinary, wine and spirits tasting event featuring fine cuisine and signature products from some New York restaurants.
The event is dedicated to raising money and awareness for Type 1, or juvenile diabetes.
Chill International launches cooling towel for hot flashes, night sweats
KEY WEST, Fla. Chill International on Thursday announced the launch of a new menopausal cooling towel, called Chill Cooling Towels, which provides relief for hot flashes and night sweats.
The Chill Towels were first introduced in many Walgreens in Florida this spring, the company reported.
“Initial consumer response has been overwhelming,” stated Allan Wimer, Chill CEO. “Consumers love the fact that the towels do not need to be chilled and are genuinely amazed at how long the towel’s cooling sensation lasts,” he said. “In fact, consumer tests indicate the cooling sensation lasts up to 2-3 hours depending on climate conditions.”
The towels are available in three sizes.
Dietary supplement recalled after FDA discovers Rx-only ingredient
NEW YORK Universal ABC Beauty Supply International on Monday recalled its dietary supplement diet aid products after the Food and Drug Administration determined the supplements contained sibutramine, a prescription-only ingredient used as an appetite suppressant for weight loss.
FDA advises that these products pose a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.